What is LOPJLB’s current signal on DMAC?

LOPJLB’s latest quantitative signal on DiaMedica Therapeutics Inc. (DMAC) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is DMAC in?

DiaMedica Therapeutics Inc. (DMAC) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does DiaMedica Therapeutics Inc. (DMAC) do?

DiaMedica Therapeutics Inc. operates as a clinical-stage biopharmaceutical entity dedicated to advancing therapeutic solutions for neurological and renal disorders. Its primary drug candidate, DM199, a recombinant human tissue kallikrein-1 protein, is currently undergoing a Phase 2 REDUX trial to assess its efficacy in treating moderate to severe chronic kidney disease linked to Type 1 or Type …

Where is DiaMedica Therapeutics Inc. based / listed?

DiaMedica Therapeutics Inc. is based in US, listed on NASDAQ.

DiaMedica Therapeutics Inc. (DMAC) Stock · SELL · RECOVERY

Key stats

Short interest · FINRA settlement 2026-07-31

Market cap: $351M
Avg volume: 185.7K
Beta: 0.97
P/E (TTM): -9.06

Short % float: 19.23%
Days to cover: 27.4
SI change: +1.8%

1W: -1.51%
1M: -3.26%
3M: +10.32%
YTD: -17.78%

vs SPY 1W: -0.32%
vs SPY 1M: -6.59%
vs SPY 3M: +7.93%
vs SPY YTD: -29.53%

Sector peers

Same-sector names ranked by LOPJLB quality proximity · Healthcare

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

DiaMedica Therapeutics Inc. (DMAC)

Key stats

Sector peers

Industry peers

Prediction markets

ANALYST & RATINGS

Company news